References
- Seyahi E, Fresko I, Melikoglu M, Yazici H. The management of Behçet's syndrome. Acta Reumatol Port 2006; 31: 125–131
- Ozdogu H, Boga C, Yilmaz Z, Sahin F L, Bal N. Long-term colchicine therapy in a patient with Behçet's disease and acute promyelocytic leukemia. Rheumatol Int 2007; 27: 763–765
- Cakmak S K, Gul U, Kilic A, Gonul M, Soylu S, Demirel O. Behçet's disease associated with chronic myelogenous leukemia and chronic graft-vs.-host disease. Leuk Lymphoma 2006; 47: 2674–2675
- Nonami A, Takenaka K, Sumida C, Aizawa K, Kamezaki K, Miyamaoto T, et al. Successful treatment of myelodysplastic syndrome (MDS)-related intestinal Behçet's disease by up-front cord blood transplantation. Intern Med 2007; 46: 1753–1756
- International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet 1990; 335: 1078–1080
- Durie B G, Harousseau J L, Miguel J S, Bladé J, Barlogie B, Anderson K, et al. International uniform response criteria for multiple myeloma. Leukemia 2006; 20: 1467–1473
- Gul A. Standard and novel therapeutic approaches to Behçet's disease. Drugs 2007; 67: 2013–2022
- Shek L P, Lim D L. Thalidomide in Behçet's disease. Biomed Pharmacother 2002; 56: 31–35
- Direskeneli H, Ergun T, Yavuz S, Hamuryudan V, Eksioglu-Demiralp E. Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease. Clin Rheumatol 2008; 27: 373–375
- Cavallo F, Boccadoro M, Palumbo A. Review of thalidomide in the treatment of newly diagnosed multiple myeloma. Ther Clin Risk Manag 2007; 3: 543–552
- Dimopoulas M A, Kastritis E, Rajkumar S V. Treatment of plasma cell dyscrasias with lenalidomide. Leukemia 2008; 22: 1343–1353
- Green J, Upjohn E, McCormack C, Zeldis J, Prince H M. Successful treatment of Behçet's disease with lenalidomide. Br J Dermatol 2008; 158: 197–198
- Sfikakis P P, Markomichelakis N, Alpsoy E, Assaad-khalil S, Bodaghi B, Gul A, et al. Anti-TNF therapy in the management of Behcet's disease: review and basis for recommendations. Rheumatology 2007; 46: 736–741
- Daikeler T, Kotter I, Booelli-Tyndall C, Apperey J, Attarbaschi A, Guardiola P, et al. A retrospective analysis of patients recorded in the European bone marrow transplantation and European league against rheumatism databases and a review of the literature. Ann Rheum Dis 2007; 66: 202–207
- Marmont A M, Gualandi F, Piaagio G, Podesta M, Teresa van Lint M, Bacigaluopo A, et al. Allogeneic bone marrow transplantation (BMT) for refractory Behçet's disease with severe CNS involvement. Bone Marrow Transplant 2006; 37: 1061–1063